LELAND DENNIS
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- GUTHRIE, OK
- NPI
- 1033155197
- Received
- $4,749 in 157 records, 2020 to 2023 ($3,194 general, $1,555 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 51 | $2,185 |
| 2022 | General payment | 60 | $626 |
| 2021 | General payment | 39 | $381 |
| 2020 | Research payment | 7 | $1,555 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 7 | $1,555 | 2020 |
| Alkermes, Inc. | 13 | $1,081 | 2022–2023 |
| Janssen Pharmaceuticals, Inc | 33 | $786 | 2021–2023 |
| ABBVIE INC. | 63 | $481 | 2021–2023 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 | 2021–2023 |
| Teva Pharmaceuticals USA, Inc. | 9 | $142 | 2023 |
| Lundbeck LLC | 6 | $131 | 2023 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $108 | 2021 |
| Indivior Inc. | 6 | $97 | 2022–2023 |
| Vanda Pharmaceuticals Inc. | 4 | $82 | 2022 |
| Neurocrine BioSciences, Inc. | 3 | $63 | 2022–2023 |
| Axsome Therapeutics, Inc. | 1 | $26 | 2023 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 | 2022 |
| Sage Therapeutics, LLC | 1 | $15 | 2021 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 149 | $2,394 |
| Research payment | 7 | $1,555 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $800 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-06-29 | Alkermes, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-06-19 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-06-14 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-06-13 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-06-08 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-06-07 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-06-07 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-06-06 | Janssen Pharmaceuticals, Inc | $0 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-06-02 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-24 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-05-23 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-05-22 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-05-19 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-18 | Indivior Inc. | $12 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-05-16 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-16 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-11 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-05-10 | Janssen Pharmaceuticals, Inc | $257 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-10 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-05-10 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-09 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-05-09 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-05 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-04-27 | Indivior Inc. | $15 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-04-26 | Lundbeck LLC | $26 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-04-25 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA TRINZA Drug, Neuroscience | 2023 | |
| 2023-04-19 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-04-13 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-04-12 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-04-06 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-04-04 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-04-03 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-03-31 | Janssen Pharmaceuticals, Inc | $122 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-03-29 | Janssen Pharmaceuticals, Inc | $121 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-03-21 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-03-15 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-03-09 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-03-08 | Indivior Inc. | $13 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-03-07 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-02-28 | Neurocrine BioSciences, Inc. | $33 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-02-23 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-02-21 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-02-15 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-02-14 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-02-13 | Indivior Inc. | $15 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-02-07 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-02-02 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-02-01 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-01-24 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-01-18 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-01-03 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2022-12-20 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-11-17 | Indivior Inc. | $16 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2022 | |
| 2022-11-03 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-10-27 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-10-25 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-10-20 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-10-18 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-10-12 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-10-05 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-10-04 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-04 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-09-29 | Sunovion Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-09-22 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-09-19 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-09-12 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-09-08 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-09-02 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-08-26 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-08-17 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 | |
| 2022-08-09 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-08-01 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-27 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-07-25 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-21 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-07-18 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-15 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-11 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-07-06 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-30 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-27 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-24 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-06-21 | Janssen Pharmaceuticals, Inc | $10 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-06-16 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-06-13 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-07 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-06-06 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-01 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-13 | Janssen Pharmaceuticals, Inc | $9 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-05-13 | Janssen Pharmaceuticals, Inc | $3 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-05-12 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-09 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-04 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-25 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-20 | Janssen Pharmaceuticals, Inc | $0 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-04-13 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-04-11 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-08 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-04-05 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-04-04 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-22 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-21 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-14 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-07 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-04 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-03-02 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-02-22 | Indivior Inc. | $23 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2022 | |
| 2022-01-21 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-13 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-12 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-01-07 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2021-12-22 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-12-17 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-12-10 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-12-08 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2021 | |
| 2021-12-03 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-11-30 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-11-23 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2021 | |
| 2021-11-19 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-11-11 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-10-22 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-10-15 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-10-07 | Sage Therapeutics, LLC | $15 | Food and Beverage | In-kind items and services | ZULRESSO Drug, PSYCHIATRYPSYCHOLOGY | 2021 | |
| 2021-10-01 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-24 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-16 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-10 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-31 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-20 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-19 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-13 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-07-30 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-07-23 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-07-16 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-07-09 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-30 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-25 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-10 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-04 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-05-28 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-05-19 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-05-15 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-05-07 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-04-17 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-04-09 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-03-30 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-03-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $108 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-03-18 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-03-11 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-02-23 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2020-02-29 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $362 | Research payment | In-kind items and services | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
| 2020-02-29 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $142 | Research payment | In-kind items and services | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
| 2020-02-29 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $55 | Research payment | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
| 2020-02-29 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $50 | Research payment | In-kind items and services | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
| 2020-02-29 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $50 | Research payment | In-kind items and services | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
| 2020-02-28 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $752 | Research payment | In-kind items and services | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
| 2020-02-28 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $142 | Research payment | In-kind items and services | REXULTI Drug, PSYCHIATRY | BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Guthrie, OK, county Logan County, OK, state Oklahoma; placed by its city name.
| Measure | Place (city or town) Guthrie, OK | County Logan County, OK | State Oklahoma |
|---|---|---|---|
| Population B01003 | 11,243 | 51,938 | 4,028,634 |
| Population, 2020 census P1 | 10,749 | 49,555 | 3,959,353 |
| Median age B01002 | 39.7 | 40.6 | 37.0 |
| Under 18 B01001 | 18.3% | 22.0% | 24.0% |
| 65 and over B01001 | 20.4% | 17.5% | 16.3% |
| Households B11001 | 4,055 | 17,834 | 1,562,389 |
| Foreign born B05002 | 3.1% | 3.8% | 6.4% |
| Median household income B19013 | $53,457 | $83,899 | $65,039 |
| Median family income B19113 | $72,318 | $97,181 | $82,385 |
| Per capita income B19301 | $28,484 | $39,998 | $35,624 |
| Poverty rate B17001 | 19.4% | 11.6% | 15.3% |
| Unemployment rate B23025 | 5.6% | 3.6% | 5.0% |
| Civilian labor force B23025 | 5,604 | 24,435 | 1,921,413 |
| Mean commute (minutes) B08013 | 24.2 | 29.0 | 22.4 |
| Bachelor's degree or higher B15003 | 26.6% | 31.4% | 28.3% |
| Housing units B25001 | 4,552 | 19,479 | 1,775,127 |
| Owner-occupied B25003 | 65.2% | 85.2% | 65.8% |
| Renters B25003 | 34.8% | 14.8% | 34.2% |
| Median home value B25077 | $186,600 | $246,700 | $199,800 |
| Median gross rent B25064 | $870 | $891 | $1,014 |
| White, not Hispanic B03002 | 66.1% | 74.5% | 62.1% |
| Black B03002 | 12.9% | 5.7% | 6.8% |
| Hispanic or Latino B03002 | 11.1% | 9.0% | 12.7% |
| Asian B03002 | 0.6% | 0.6% | 2.4% |
| American Indian and Alaska Native B03002 | 2.7% | 2.6% | 6.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Guthrie, OK.
Comments